Urteste (URT.WA) Stock Price

Urteste Price

CLOSED
42.80
​
Market closed

Over the last 3 years Urteste grew revenue by 94.3% annually, reaching 22,000.00 PLN. For Urteste, the net margin of -27,186.4% is up versus -135,333.3% a few years ago.

Urteste stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Urteste business model & stock analysis

Urteste SA specializes in the development of technology that allows the detection of cancers at early stages of their development. The company is headquartered in Gdansk, Woj. Pomorskie. The company went IPO on 2021-10-27. The firm operates in the field of medical devices for in vitro application in the field of cancer diagnostics. The technology developed by the Company involves the detection of cancer by measuring the activity of enzymes in a urine sample, using diagnostic tests that enable the detection of common cancers in their early stages. The firm offers tests for the detection of cancers such as, pancreatic cancer, prostate cancer, colorectal cancer, lung cancer, kidney cancer, liver cancer, biliary tract cancer, stomach cancer, esophageal cancer, ovarian cancer, endometrial cancer, breast cancer, leukemia, lymphoma, glioma.

Frequently asked questions about Urteste

Converted at the current exchange rate, the Urteste share trades at 9.79 EUR (42.80 PLN).

The revenue cannot currently be calculated for Urteste.

The profit cannot currently be calculated for Urteste.

The P/E ratio cannot be calculated for Urteste at the moment.

The P/S cannot be calculated for Urteste currently.

The Eulerpool Quality Score for Urteste is 3/10.

The ISIN of Urteste is PLURTST00010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Urteste is URT.WA. The ticker symbol is used to trade Urteste shares on the stock exchange.

Fair ValueTerminal
38.52 PLN
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website urteste.eu
Country
Poland
Currency
PLN
Initial public offering
Oct 27, 2021
ISIN
PLURTST00010
Cusip
X95247114
Market capitalization
65.48 M PLNMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.63
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-21.43 %
Last updated Oct 20, 2026, 3:44 AM

Urteste Peer Group

Urteste FIGI

URT:PW · BBG0136J6WT6

All fundamentals and in-depth analysis of Urteste

Our stock analysis for Urteste stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Urteste. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.